1. Home
  2. HALO vs FRHC Comparison

HALO vs FRHC Comparison

Compare HALO & FRHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • FRHC
  • Stock Information
  • Founded
  • HALO 1998
  • FRHC 1981
  • Country
  • HALO United States
  • FRHC United States
  • Employees
  • HALO N/A
  • FRHC N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • FRHC Investment Bankers/Brokers/Service
  • Sector
  • HALO Health Care
  • FRHC Finance
  • Exchange
  • HALO Nasdaq
  • FRHC Nasdaq
  • Market Cap
  • HALO 7.4B
  • FRHC 7.8B
  • IPO Year
  • HALO N/A
  • FRHC N/A
  • Fundamental
  • Price
  • HALO $50.23
  • FRHC $163.61
  • Analyst Decision
  • HALO Buy
  • FRHC
  • Analyst Count
  • HALO 9
  • FRHC 0
  • Target Price
  • HALO $63.78
  • FRHC N/A
  • AVG Volume (30 Days)
  • HALO 2.6M
  • FRHC 66.9K
  • Earning Date
  • HALO 05-06-2025
  • FRHC 06-13-2025
  • Dividend Yield
  • HALO N/A
  • FRHC N/A
  • EPS Growth
  • HALO 55.40
  • FRHC N/A
  • EPS
  • HALO 3.76
  • FRHC 5.36
  • Revenue
  • HALO $1,084,306,000.00
  • FRHC $1,578,152,000.00
  • Revenue This Year
  • HALO $24.79
  • FRHC N/A
  • Revenue Next Year
  • HALO $22.65
  • FRHC N/A
  • P/E Ratio
  • HALO $13.36
  • FRHC $29.91
  • Revenue Growth
  • HALO 25.64
  • FRHC 79.07
  • 52 Week Low
  • HALO $41.28
  • FRHC $68.82
  • 52 Week High
  • HALO $70.51
  • FRHC $164.83
  • Technical
  • Relative Strength Index (RSI)
  • HALO 34.42
  • FRHC 74.56
  • Support Level
  • HALO $58.38
  • FRHC $138.99
  • Resistance Level
  • HALO $69.94
  • FRHC $157.99
  • Average True Range (ATR)
  • HALO 3.30
  • FRHC 4.43
  • MACD
  • HALO -0.27
  • FRHC 2.18
  • Stochastic Oscillator
  • HALO 9.30
  • FRHC 95.65

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About FRHC Freedom Holding Corp.

Freedom Holding Corp is a holding company with its subsidiary it is engaged in securities brokerage, securities dealing for customers and account, market-making activities, investment research, investment counseling, investment banking services, retail and commercial banking, insurance products, payment services, and information processing services. It acts as a professional participant through its subsidiaries on the Kazakhstan Stock Exchange (KASE), Moscow Exchange (MOEX), Saint-Petersburg Exchange (SPB), the Ukrainian Exchange, the Uzbek Republican Currency Exchange (UZCE), and the Republican Stock Exchange of Tashkent (UZSE). Its segments are Brokerage, Banking, Insurance, and Others.

Share on Social Networks: